SCHEMBL7980997

SCHEMBL7980997

Clc1ccc2nc(Nc3ccccc3Cl)c3cncn3c2c1

nearest known ligand 0.77

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 18/20 0.77
LYN P07948 2/20 0.55
BTK Q06187 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969628 0.90 LCK (0.77) LCKLYNBTK
SCHEMBL7981144 0.88 LCK (0.74) LCKLYNBTK
SCHEMBL7970143 0.88 LCK (0.77) LCKLYNBTK
SCHEMBL7979866 0.87 LCK (1.00) LCK
SCHEMBL7982170 0.85 LCK (0.79) LCK
SCHEMBL7983951 0.85 LCK (0.73) LCKLYNBTK
SCHEMBL7969592 0.79 LCK (0.83) LCK
SCHEMBL7983457 0.79 LCK (0.74) LCK
SCHEMBL7970071 0.79 LCK (0.72) LCKLYNBTK
SCHEMBL7969998 0.79 LCK (0.69) LCKLYNBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed